F17.221 — Nicotine dependence, chewing tobacco, in remission
Is F17.221 billable?
Yes — F17.221 is billable for FY2027. F17.221 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. F17.221 may be submitted for encounters from October 1, 2026 through September 30, 2027.
F17.221 at a glance
| Code | F17.221 |
|---|---|
| Description | Nicotine dependence, chewing tobacco, in remission |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
What Medicare edits apply to F17.221?
The Medicare Code Editor screens inpatient claims before they are grouped. These edits name F17.221 directly.
CMS will reject this code as the principal diagnosis on an inpatient claim. It describes something other than the condition chiefly responsible for the admission.
Which MS-DRGs does F17.221 group to?
F17.221 sits in MDC 23 and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 951Other Factors Influencing Health Statusmedical
How is F17.221 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to F17.221. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Disorder › tobacco use › chewing tobacco › in remission (of)
- Dependence › drug NEC › nicotine › chewing tobacco › with disorder › in remission (on) (syndrome)
Inclusion terms
Alternative wording in documentation that is classified to F17.221.
- Tobacco use disorder, chewing tobacco, mild, in early remission
- Tobacco use disorder, chewing tobacco, mild, in sustained remission
- Tobacco use disorder, chewing tobacco, moderate, in early remission
- Tobacco use disorder, chewing tobacco, moderate, in sustained remission
- Tobacco use disorder, chewing tobacco, severe, in early remission
- Tobacco use disorder, chewing tobacco, severe, in sustained remission
Excludes1 — never code together — inherited from F17
The conditions below can never be reported together with F17.221 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
Excludes2 — not included here — inherited from Chapter 5
The conditions below are not part of F17.221, but a patient may have both at the same time. When documentation supports it, F17.221 and the excluded code may both be reported.
- symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)
Excludes2 — not included here — inherited from F17
The conditions below are not part of F17.221, but a patient may have both at the same time. When documentation supports it, F17.221 and the excluded code may both be reported.
How long has F17.221 existed?
F17.221 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.